ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2019. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $35,000 | -79.9% | 26,951 | -46.1% | 0.00% | – |
Q3 2018 | $174,000 | +2385.7% | 49,975 | +2102.5% | 0.00% | – |
Q2 2018 | $7,000 | -70.8% | 2,269 | -67.9% | 0.00% | – |
Q1 2018 | $24,000 | +2300.0% | 7,067 | +2881.9% | 0.00% | – |
Q4 2017 | $1,000 | – | 237 | +47.2% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 161 | -84.8% | 0.00% | – |
Q2 2017 | $5,000 | – | 1,061 | +21120.0% | 0.00% | – |
Q1 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 5 | 0.0% | 0.00% | – |
Q3 2016 | $0 | -100.0% | 5 | -100.0% | 0.00% | – |
Q2 2016 | $50,000 | – | 18,138 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greenlight Capital | 1,000,000 | $1,100,000 | 0.07% |
Hayden Royal, LLC | 40,015 | $44,000 | 0.02% |
Verdence Capital Advisors LLC | 143,382 | $158,000 | 0.02% |
Founders Capital Management | 18,000 | $20,000 | 0.01% |
WOLFF WIESE MAGANA LLC | 10,740 | $12,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 1,622,510 | $1,785,000 | 0.01% |
Global Strategic Investment Solutions, LLC | 23,000 | $25,000 | 0.00% |
Stonebridge Capital Advisors LLC | 44,000 | $45,000 | 0.00% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $110,000 | 0.00% |
PRELUDE CAPITAL MANAGEMENT, LLC | 97,590 | $107,000 | 0.00% |